NCT06426355View on ClinicalTrials.gov

The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions
Diminished Ovarian Reserve
Interventions
DIETARY_SUPPLEMENT

NMN

NMN capsules (total of 600mg/day) for 2-5 months

OTHER

Placebo

NMN-free placebo capsules for 2-5 months

Trial Locations (1)

100000

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER